An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

546

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions
Major Depressive Disorder (MDD)
Interventions
DRUG

Radafaxine

Trial Locations (29)

6708

GSK Investigational Site, Farmington

11559

GSK Investigational Site, Lawrence

19428

GSK Investigational Site, Conshohocken

21061

GSK Investigational Site, Glen Burnie

28203

GSK Investigational Site, Charlotte

32751

GSK Investigational Site, Maitland

33156

GSK Investigational Site, Miami

33161

GSK Investigational Site, North Miami

33773

GSK Investigational Site, Largo

44106

GSK Investigational Site, Cleveland

45408

GSK Investigational Site, Dayton

48336

GSK Investigational Site, Farmington Hills

53223

GSK Investigational Site, Brown Deer

55454

GSK Investigational Site, Minneapolis

62025

GSK Investigational Site, Edwardsville

72223

GSK Investigational Site, Little Rock

73118

GSK Investigational Site, Oklahoma City

75039

GSK Investigational Site, Irving

75235

GSK Investigational Site, Dallas

77004

GSK Investigational Site, Houston

97209

GSK Investigational Site, Portland

97210

GSK Investigational Site, Portland

97401

GSK Investigational Site, Eugene

98104

GSK Investigational Site, Seattle

98499

GSK Investigational Site, Tacoma

92660-2814

GSK Investigational Site, Newport Beach

08021

GSK Investigational Site, Clementon

07033

GSK Investigational Site, Kenilworth

05091

GSK Investigational Site, Woodstock

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY